Iovance Biotherapeutics (IOVA) Down 2.1% Since Last Earnings Report: Can It Rebound?

It has been about a month since the last earnings report for Iovance Biotherapeutics (IOVA) . Shares have lost about 2.1% in that time frame, outperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Iovance Biotherapeutics due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.Q4 Earnings & Sales Bea ...